{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T21:27:01Z","timestamp":1789594021608,"version":"build-2803163510"},"reference-count":58,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Psychiatry Research: Neuroimaging"],"published-print":{"date-parts":[[2026,12]]},"DOI":"10.1016\/j.pscychresns.2026.112289","type":"journal-article","created":{"date-parts":[[2026,7,24]],"date-time":"2026-07-24T00:37:58Z","timestamp":1784853478000},"page":"112289","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Combining neuromelanin-sensitive MRI and quantitative susceptibility mapping for enhanced diagnosis and differentiation of parkinson\u2019s disease: A systematic review"],"prefix":"10.1016","volume":"363","author":[{"given":"Farzane","family":"Nikparast","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammad","family":"Danesh-Doust","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hoda","family":"Zare","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"11","key":"10.1016\/j.pscychresns.2026.112289_bib0001","doi-asserted-by":"crossref","first-page":"1288","DOI":"10.1136\/jnnp-2012-304436","article-title":"Clinical utility of dopamine transporter single photon emission CT (DaT-SPECT) with (<sup>123<\/sup>I) ioflupane in diagnosis of parkinsonian syndromes","volume":"84","author":"Bajaj","year":"2013","journal-title":"J. Neurol. Neurosurg. Amp; Psychiatry"},{"issue":"12","key":"10.1016\/j.pscychresns.2026.112289_bib0003","doi-asserted-by":"crossref","first-page":"1600","DOI":"10.1002\/mds.26431","article-title":"MDS research criteria for prodromal Parkinson's disease","volume":"30","author":"Berg","year":"2015","journal-title":"Mov. Disord."},{"issue":"7","key":"10.1016\/j.pscychresns.2026.112289_bib0004","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1002\/mds.27730","article-title":"Ventral posterior substantia nigra iron increases over 3 years in Parkinson's disease","volume":"34","author":"Bergsland","year":"2019","journal-title":"Mov. Disord."},{"issue":"10","key":"10.1016\/j.pscychresns.2026.112289_bib65","doi-asserted-by":"crossref","first-page":"3114","DOI":"10.1093\/brain\/awab191","article-title":"The spatiotemporal changes in dopamine, neuromelanin and iron characterizing Parkinson\u2019s disease","volume":"144","author":"Biondetti","year":"2021","journal-title":"Brain"},{"issue":"6","key":"10.1016\/j.pscychresns.2026.112289_bib0005","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1212\/WNL.0b013e31829e6fd2","article-title":"Visualization of nigrosome 1 and its loss in PD: pathoanatomical correlation and in vivo 7 T MRI","volume":"81","author":"Blazejewska","year":"2013","journal-title":"Neurology"},{"issue":"8","key":"10.1016\/j.pscychresns.2026.112289_bib0006","doi-asserted-by":"crossref","first-page":"2183","DOI":"10.1093\/brain\/awx146","article-title":"Progression marker of Parkinson\u2019s disease: a 4-year multi-site imaging study","volume":"140","author":"Burciu","year":"2017","journal-title":"Brain"},{"key":"10.1016\/j.pscychresns.2026.112289_bib0007","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.parkreldis.2020.07.002","article-title":"Diagnostic accuracy of the appearance of Nigrosome-1 on magnetic resonance imaging in Parkinson's disease: a systematic review and meta-analysis","volume":"78","author":"Chau","year":"2020","journal-title":"Parkinsonism. Relat. Disord."},{"key":"10.1016\/j.pscychresns.2026.112289_bib0008","doi-asserted-by":"crossref","DOI":"10.3389\/fnagi.2024.1397896","article-title":"An automated hybrid approach via deep learning and radiomics focused on the midbrain and substantia nigra to detect early-stage Parkinson\u2019s disease [Article]","volume":"16","author":"Chen","year":"2024","journal-title":"Front. Aging Neurosci."},{"key":"10.1016\/j.pscychresns.2026.112289_bib0011","doi-asserted-by":"crossref","DOI":"10.1016\/j.nbd.2025.107076","article-title":"Multimodal MRI biomarkers optimize differentiation between progressive supranuclear palsy and Parkinson's disease [Article]","volume":"215","author":"Chen","year":"2025","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.pscychresns.2026.112289_bib0012","article-title":"Imaging the nigrosome 1 in the substantia nigra using susceptibility weighted imaging and quantitative susceptibility mapping: an application to Parkinson's disease","volume":"25","author":"Cheng","year":"2020","journal-title":"NeuroImage: Clin."},{"issue":"6","key":"10.1016\/j.pscychresns.2026.112289_bib71","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1002\/ana.21995","article-title":"Clinical progression in Parkinson disease and the neurobiology of axons","volume":"67","author":"Cheng","year":"2010","journal-title":"Annals of Neurology"},{"issue":"8","key":"10.1016\/j.pscychresns.2026.112289_bib74","doi-asserted-by":"crossref","first-page":"1437","DOI":"10.1093\/brain\/122.8.1437","article-title":"The substantia nigra of the human brain: II. Patterns of loss of dopamine-containing neurons in Parkinson\u2019s disease","volume":"122","author":"Damier","year":"1999","journal-title":"Brain"},{"key":"10.1016\/j.pscychresns.2026.112289_bib0013","first-page":"165","article-title":"Parkinson's disease society brain bank, london: overview and research","volume":"39","author":"Daniel","year":"1993","journal-title":"J. Neural Transm. Suppl."},{"issue":"6","key":"10.1016\/j.pscychresns.2026.112289_bib0014","doi-asserted-by":"crossref","first-page":"1830","DOI":"10.1111\/j.1471-4159.1989.tb07264.x","article-title":"Increased nigral iron content and alterations in other metal ions occurring in brain in Parkinson's Disease","volume":"52","author":"Dexter","year":"1989","journal-title":"J. Neurochem."},{"issue":"1","key":"10.1016\/j.pscychresns.2026.112289_bib76","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1001\/jamaneurol.2017.3299","article-title":"The Parkinson pandemic\u2014A call to action","volume":"75","author":"Dorsey","year":"2018","journal-title":"JAMA Neurology"},{"issue":"5","key":"10.1016\/j.pscychresns.2026.112289_bib67","doi-asserted-by":"crossref","first-page":"2283","DOI":"10.1093\/brain\/114.5.2283","article-title":"Ageing and Parkinson\u2019s disease: substantia nigra regional selectivity","volume":"114","author":"Fearnley","year":"1991","journal-title":"Brain"},{"issue":"1","key":"10.1016\/j.pscychresns.2026.112289_bib0016","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1007\/s11604-025-01858-7","article-title":"Integrated evaluation of nigrosome 1 sign, neuromelanin-sensitive MR and iron deposition [Article]","volume":"44","author":"Fushimi","year":"2026","journal-title":"Jpn. J. Radiol."},{"issue":"3","key":"10.1016\/j.pscychresns.2026.112289_bib0018","doi-asserted-by":"crossref","DOI":"10.1093\/braincomms\/fcaf212","article-title":"Early brain iron changes in Parkinson's disease and isolated rapid eye movement sleep behaviour disorder: a four-year longitudinal multimodal quantitative MRI study","volume":"7","author":"Gaurav","year":"2025","journal-title":"Brain Commun."},{"issue":"7650","key":"10.1016\/j.pscychresns.2026.112289_bib0019","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1136\/bmj.39489.470347.AD","article-title":"GRADE: an emerging consensus on rating quality of evidence and strength of recommendations","volume":"336","author":"Guyatt","year":"2008","journal-title":"BMJ"},{"issue":"3","key":"10.1016\/j.pscychresns.2026.112289_bib0020","doi-asserted-by":"crossref","first-page":"281","DOI":"10.31887\/DCNS.2004.6.3\/ahartmann","article-title":"Postmortem studies in Parkinson's disease","volume":"6","author":"Hartmann","year":"2004","journal-title":"Dialogues. Clin. Neurosci."},{"key":"10.1016\/j.pscychresns.2026.112289_bib0021","doi-asserted-by":"crossref","DOI":"10.3389\/fnagi.2023.1287917","article-title":"Quantitative iron-neuromelanin MRI associates with motor severity in Parkinson's disease and matches radiological disease classification","volume":"15","author":"Hartono","year":"2023","journal-title":"Front. Aging Neurosci."},{"key":"10.1016\/j.pscychresns.2026.112289_bib0023","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuroimage.2021.117810","article-title":"Imaging iron and neuromelanin simultaneously using a single 3D gradient echo magnetization transfer sequence: combining neuromelanin, iron and the nigrosome-1 sign as complementary imaging biomarkers in early stage Parkinson's disease","volume":"230","author":"He","year":"2021","journal-title":"Neuroimage"},{"issue":"8","key":"10.1016\/j.pscychresns.2026.112289_bib0024","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1007\/s00702-017-1717-8","article-title":"Magnetic resonance imaging for the diagnosis of Parkinson\u2019s disease","volume":"124","author":"Heim","year":"2017","journal-title":"J. Neural Transm."},{"issue":"3","key":"10.1016\/j.pscychresns.2026.112289_bib0025","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1080\/14737175.2017.1256205","article-title":"Clinical utility of DaTscan\u2122 imaging in the evaluation of patients with parkinsonism: a US perspective","volume":"17","author":"Isaacson","year":"2017","journal-title":"Expert. Rev. NeurOther"},{"key":"10.1016\/j.pscychresns.2026.112289_bib0027","doi-asserted-by":"crossref","first-page":"100","DOI":"10.3389\/fneur.2019.00100","article-title":"Combined visualization of nigrosome-1 and neuromelanin in the Substantia Nigra using 3T MRI for the differential diagnosis of essential tremor and de novo Parkinson's disease","volume":"10","author":"Jin","year":"2019","journal-title":"Front. Neurol."},{"key":"10.1016\/j.pscychresns.2026.112289_bib0029","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuroimage.2022.119814","article-title":"Diagnosing Parkinson's disease by combining neuromelanin and iron imaging features using an automated midbrain template approach","volume":"266","author":"Jokar","year":"2023","journal-title":"Neuroimage"},{"issue":"9996","key":"10.1016\/j.pscychresns.2026.112289_bib68","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1016\/S0140-6736(14)61393-3","article-title":"Parkinson\u2019s disease","volume":"386","author":"Kalia","year":"2015","journal-title":"The Lancet"},{"key":"10.1016\/j.pscychresns.2026.112289_bib0030","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1016\/j.neuroimage.2017.11.035","article-title":"Specific visualization of neuromelanin-iron complex and ferric iron in the human post-mortem substantia nigra using MR relaxometry at 7T","volume":"172","author":"Lee","year":"2018","journal-title":"Neuroimage"},{"issue":"13","key":"10.1016\/j.pscychresns.2026.112289_bib0031","doi-asserted-by":"crossref","first-page":"1574","DOI":"10.1002\/mds.26043","article-title":"7 Tesla magnetic resonance imaging: a closer look at substantia nigra anatomy in Parkinson's disease","volume":"29","author":"Leh\u00e9ricy","year":"2014","journal-title":"Mov. Disord."},{"issue":"13","key":"10.1016\/j.pscychresns.2026.112289_bib75","doi-asserted-by":"crossref","first-page":"1574","DOI":"10.1002\/mds.26043","article-title":"7 tesla magnetic resonance imaging: A closer look at substantia nigra anatomy in Parkinson\u2019s disease","volume":"29","author":"Leh\u00e9ricy","year":"2014","journal-title":"Movement Disorders"},{"key":"10.1016\/j.pscychresns.2026.112289_bib0032","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuroimage.2026.122046","article-title":"Membrane and bioenergetic dysfunction in Parkinson's disease with REM sleep behavior disorder: a 31P and 1H MR study","volume":"338","author":"Li","year":"2026","journal-title":"Neuroimage"},{"issue":"1","key":"10.1016\/j.pscychresns.2026.112289_bib0034","doi-asserted-by":"crossref","DOI":"10.1186\/s12883-020-01828-8","article-title":"Short-echo-time magnitude image derived from quantitative susceptibility mapping could resemble neuromelanin-sensitive MRI image in substantia nigra","volume":"20","author":"Liu","year":"2020","journal-title":"BMC. Neurol."},{"issue":"3","key":"10.1016\/j.pscychresns.2026.112289_bib0038","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1002\/mds.70153","article-title":"Integration of volumetric, iron, and neuromelanin magnetic resonance imaging measures effectively differentiates Parkinson's Disease from multiple system atrophy [Article]","volume":"41","author":"Liu","year":"2026","journal-title":"Mov. Disord."},{"issue":"1","key":"10.1016\/j.pscychresns.2026.112289_bib0040","doi-asserted-by":"crossref","DOI":"10.1038\/s41531-025-00972-7","article-title":"High-resolution mapping of substantia nigra in Parkinson's disease using 7 tesla magnetic resonance imaging","volume":"11","author":"Madelung","year":"2025","journal-title":"Npj Parkinsons Dis."},{"issue":"10","key":"10.1016\/j.pscychresns.2026.112289_bib0041","doi-asserted-by":"crossref","first-page":"1262","DOI":"10.1001\/jamaneurol.2021.1312","article-title":"Emerging neuroimaging biomarkers across disease stage in Parkinson Disease: a review","volume":"78","author":"Mitchell","year":"2021","journal-title":"JAMA Neurol."},{"issue":"1","key":"10.1016\/j.pscychresns.2026.112289_bib0042","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1186\/s13244-022-01207-6","article-title":"Brain pathological changes during neurodegenerative diseases and their identification methods: how does QSM perform in detecting this process?","volume":"13","author":"Nikparast","year":"2022","journal-title":"Insights. ImAging"},{"issue":"1","key":"10.1016\/j.pscychresns.2026.112289_bib0043","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1186\/s12868-022-00725-9","article-title":"Early differentiation of neurodegenerative diseases using the novel QSM technique: what is the biomarker of each disorder?","volume":"23","author":"Nikparast","year":"2022","journal-title":"BMC. Neurosci."},{"issue":"2","key":"10.1016\/j.pscychresns.2026.112289_bib0044","first-page":"130","article-title":"Application of Nobel QSM technique in MRI for diagnosis of Alzheimer's disease: what is the relationship between iron deposits in brain nuclei with age and severity of disorders?","volume":"45","author":"Nikparast","year":"2023","journal-title":"Med. J. Tabriz Univ. Med. Sci."},{"issue":"1","key":"10.1016\/j.pscychresns.2026.112289_bib0045","first-page":"45","article-title":"Brain nucleus changes in cognitive disorders: examining by the quantitative susceptibility mapping (QSM) technique","volume":"21","author":"Nikparast","year":"2024","journal-title":"Iran. J. Med. Phys."},{"issue":"3","key":"10.1016\/j.pscychresns.2026.112289_bib0046","first-page":"194","article-title":"A follow-up study investigating the spectrum of cognitive impairment by MRI: does iron cause cognitive dysfunction or vice versa?","volume":"21","author":"Nikparast","year":"2024","journal-title":"Iran. J. Med. Phys."},{"key":"10.1016\/j.pscychresns.2026.112289_bib0047","article-title":"PRISMA 2020 explanation and elaboration: updated guidance and exemplars for reporting systematic reviews","volume":"372","author":"Page","year":"2021","journal-title":"BMJ"},{"issue":"12","key":"10.1016\/j.pscychresns.2026.112289_bib0048","doi-asserted-by":"crossref","first-page":"1591","DOI":"10.1002\/mds.26424","article-title":"MDS clinical diagnostic criteria for Parkinson's disease","volume":"30","author":"Postuma","year":"2015","journal-title":"Mov. Dis."},{"issue":"8","key":"10.1016\/j.pscychresns.2026.112289_bib0049","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1007\/s11910-019-0964-5","article-title":"Structural imaging in Parkinson\u2019s Disease: new developments","volume":"19","author":"Prange","year":"2019","journal-title":"Curr. Neurol. Neurosci. Rep."},{"issue":"4","key":"10.1016\/j.pscychresns.2026.112289_bib72","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1002\/ana.20226","article-title":"Parkinsonian signs and substantia nigra neuron density in decedents elders without PD","volume":"56","author":"Ross","year":"2004","journal-title":"Annals of Neurology"},{"issue":"11","key":"10.1016\/j.pscychresns.2026.112289_bib0050","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1097\/01.wnr.0000227984.84927.a7","article-title":"Neuromelanin magnetic resonance imaging of locus ceruleus and substantia nigra in Parkinson's disease","volume":"17","author":"Sasaki","year":"2006","journal-title":"Neuroreport"},{"issue":"4","key":"10.1016\/j.pscychresns.2026.112289_bib0051","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0093814","article-title":"The \u2018swallow tail\u2019 Appearance of the healthy nigrosome \u2013 A new accurate test of Parkinson's disease: a case-control and retrospective cross-sectional MRI study at 3T","volume":"9","author":"Schwarz","year":"2014","journal-title":"PLoS. One"},{"issue":"4","key":"10.1016\/j.pscychresns.2026.112289_bib0053","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1002\/mds.29320","article-title":"Multimodal imaging of Substantia Nigra in Parkinson's Disease with levodopa-induced dyskinesia","volume":"38","author":"Su","year":"2023","journal-title":"Mov. Disord."},{"key":"10.1016\/j.pscychresns.2026.112289_bib0054","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1038\/s41531-018-0047-3","article-title":"Neuromelanin detection by magnetic resonance imaging (MRI) and its promise as a biomarker for Parkinson's disease","volume":"4","author":"Sulzer","year":"2018","journal-title":"NPJ. Parkinsons. Dis."},{"issue":"6","key":"10.1016\/j.pscychresns.2026.112289_bib73","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1002\/mds.25187","article-title":"Neuronal vulnerability, pathogenesis, and Parkinson\u2019s disease","volume":"28","author":"Sulzer","year":"2013","journal-title":"Movement Disorders"},{"key":"10.1016\/j.pscychresns.2026.112289_bib78","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.ejrad.2018.06.024","article-title":"Comprehensive MRI quantification of the substantia nigra pars compacta in Parkinson\u2019s disease","volume":"109","author":"Takahashi","year":"2018","journal-title":"Eur. J. Radiol."},{"key":"10.1016\/j.pscychresns.2026.112289_bib0059","article-title":"Meta-analysis of brain iron levels of Parkinson's disease patients determined by postmortem and MRI measurements","volume":"6","author":"Wang","year":"2016","journal-title":"Sci. Rep."},{"key":"10.1016\/j.pscychresns.2026.112289_bib0061","doi-asserted-by":"crossref","DOI":"10.3389\/fnagi.2024.1425095","article-title":"Classification of Parkinson's disease by deep learning on midbrain MRI","volume":"16","author":"Welton","year":"2024","journal-title":"Front. Aging Neurosci."},{"issue":"8","key":"10.1016\/j.pscychresns.2026.112289_bib0062","doi-asserted-by":"crossref","first-page":"529","DOI":"10.7326\/0003-4819-155-8-201110180-00009","article-title":"QUADAS-2: a revised tool for the quality assessment of diagnostic accuracy studies","volume":"155","author":"Whiting","year":"2011","journal-title":"Ann. Intern. Med."},{"issue":"5","key":"10.1016\/j.pscychresns.2026.112289_bib66","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/j.parkreldis.2010.02.007","article-title":"Iron and reactive oxygen species activity in parkinsonian substantia nigra","volume":"16","author":"Wypijewska","year":"2010","journal-title":"Park. Relat. Disord."},{"key":"10.1016\/j.pscychresns.2026.112289_bib70","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.neuroscience.2014.04.010","article-title":"An update on the connections of the ventral mesencephalic dopaminergic complex","volume":"282","author":"Yetnikoff","year":"2014","journal-title":"Neuroscience"},{"key":"10.1016\/j.pscychresns.2026.112289_bib0064","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/j.mri.2024.05.011","article-title":"Iron and neuromelanin imaging in basal ganglia circuitry in Parkinson ' s disease with freezing of gait","volume":"111","author":"Zhang","year":"2024","journal-title":"Magn. Reson. ImAging"},{"key":"10.1016\/j.pscychresns.2026.112289_bib69","doi-asserted-by":"crossref","first-page":"1178","DOI":"10.1016\/j.neuroimage.2021.117810","article-title":"Imaging iron and neuromelanin simultaneously using a single 3D gradient echo magnetization transfer sequence: Combining neuromelanin, iron and the nigrosome-1 sign as complementary imaging biomarkers in early stage Parkinson\u2019s disease","volume":"230","author":"He","year":"2021","journal-title":"NeuroImage"},{"issue":"1086","key":"10.1016\/j.pscychresns.2026.112289_bib77","doi-asserted-by":"crossref","first-page":"20180037","DOI":"10.1259\/bjr.20180037","article-title":"Quantifying changes in nigrosomes using quantitative susceptibility mapping and neuromelanin imaging for the diagnosis of early-stage Parkinson\u2019s disease","volume":"91","author":"Takahashi","year":"2018","journal-title":"Br. J. Radiol."}],"container-title":["Psychiatry Research: Neuroimaging"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S092549272600154X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S092549272600154X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,6]],"date-time":"2026-09-06T19:46:00Z","timestamp":1788723960000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S092549272600154X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,12]]},"references-count":58,"alternative-id":["S092549272600154X"],"URL":"https:\/\/doi.org\/10.1016\/j.pscychresns.2026.112289","relation":{},"ISSN":["0925-4927"],"issn-type":[{"value":"0925-4927","type":"print"}],"subject":[],"published":{"date-parts":[[2026,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Combining neuromelanin-sensitive MRI and quantitative susceptibility mapping for enhanced diagnosis and differentiation of parkinson\u2019s disease: A systematic review","name":"articletitle","label":"Article Title"},{"value":"Psychiatry Research: Neuroimaging","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.pscychresns.2026.112289","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"112289"}}